Moffitt Cancer Center at Tampa General Hospital — Tampa, Florida

Moffitt Cancer Center at Tampa General Hospital is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Moffitt Cancer Center at Tampa General Hospital has participated in 1 clinical trials.

Therapeutic areas: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt Cancer Center at Tampa General Hospital?

Moffitt Cancer Center at Tampa General Hospital has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt Cancer Center at Tampa General Hospital conducted?

Moffitt Cancer Center at Tampa General Hospital has 1 clinical trials on record. Their work covers Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma.

Is Moffitt Cancer Center at Tampa General Hospital accredited by Crixeo Health?

Moffitt Cancer Center at Tampa General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt Cancer Center at Tampa General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.